Yap1 plays a protective role in suppressing free fatty acid-induced apoptosis and promoting beta-cell survival

Abstract

Mammalian pancreatic β-cells play a pivotal role in development and glucose homeostasis through the production and secretion of insulin. Functional failure or decrease in β-cell number leads to type 2 diabetes (T2D). Despite the physiological importance of β-cells, the viability of β-cells is often challenged mainly due to its poor ability to adapt to their changing microenvironment. One of the factors that negatively affect β-cell viability is high concentration of free fatty acids (FFAs) such as palmitate. In this work, we demonstrated that Yes-associated protein (Yap1) is activated when β-cells are treated with palmitate. Our loss- and gain-of-function analyses using rodent insulinoma cell lines revealed that Yap1 suppresses palmitate-induced apoptosis in β-cells without regulating their proliferation. We also found that upon palmitate treatment, re-arrangement of F-actin mediates Yap1 activation. Palmitate treatment increases expression of one of the Yap1 target genes, connective tissue growth factor (CTGF). Our gain-offunction analysis with CTGF suggests CTGF may be the downstream factor of Yap1 in the protective mechanism against FFA-induced apoptosis.

Keywords

β-cell / CTGF / F-actin / free fatty acid / Hippo signaling / Yap1

References

[1] Ardestani A, Paroni F, Azizi Z, Kaur S, Khobragade V, Yuan T (2014) MST1 is a key regulator of beta cell apoptosis and dysfunction in diabetes. Nat Med 20:385–397

[2] Basu S, Totty NF, Irwin MS, Sudol M, Downward J (2003) Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol Cell 11:11–23

[3] Boden G (2008) Obesity and free fatty acids. Endocrinol Metab Clin North Am 37:635–646

[4] Boden G, Shulman GI (2002) Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 32(Suppl 3):14–23

[5] Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, Jaenisch R (2007) YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol 17:2054–2060

[6] Crawford LA, Guney MA, Oh YA, Deyoung RA, Valenzuela DM, Murphy AJ (2009) Connective tissue growth factor (CTGF) inactivation leads to defects in islet cell lineage allocation and beta-cell proliferation during embryogenesis. Mol Endocrinol 23:324–336

[7] Cunha DA, Hekerman P, Ladrière L, Bazarra-Castro A, Ortis F, Wakeham MC (2008) Initiation and execution of lipotoxic ER stress in pancreatic β-cells. J Cell Sci 121:2308–2318

[8] Eitel K, Staiger H, Brendel MD, Brandhorst D, Bretzel RG, Haring HU (2002) Different role of saturated and unsaturated fatty acids in beta-cell apoptosis. Biochem Biophys Res Commun 299:853–856

[9] Eizirik DL, Cardozo AK, Cnop M (2008) The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev 29:42–61

[10] Fan Y, Bergmann A (2008) Apoptosis-induced compensatory proliferation. The cell is dead. Long live the Cell! Trends Cell Biol 18:467–473

[11] Gao T, Zhou D, Yang C, Singh T, Penzo-Méndez A, Maddipati R (2013) Hippo signaling regulates differentiation and maintenance in the exocrine pancreas. Gastroenterology 144:1543–1553

[12] George NM, Day CE, Boerner BP, Johnson RL, Sarvetnick NE (2012) Hippo signaling regulates pancreas development through inactivation of Yap. Mol Cell Biol 32:5116–5128

[13] Gunasekaran U, Hudgens CW, Wright BT, Maulis MF, Gannon M (2012) Differential regulation of embryonic and adult β cell replication. Cell Cycle 11:2431–2442

[14] Guney MA, Petersen CP, Boustani A, Duncan MR, Gunasekaran U, Menon R (2011) Connective tissue growth factor acts within both endothelial cells and beta cells to promote proliferation of developing beta cells. Proc Natl Acad Sci USA 108:15242–15247

[15] Haber EP, Ximenes HM, Procopio J, Carvalho CR, Curi R, Carpinelli AR (2003) Pleiotropic effects of fatty acids on pancreatic beta-cells. J Cell Physiol 194:1–12

[16] Haber EP, Procópio J, Carvalho CR, Carpinelli AR, Newsholme P, Curi R (2006) New insights into fatty acid modulation of pancreatic beta-cell function. Int Rev Cytol 248:1–41

[17] Kalwat MA, Thurmond DC (2013) Signaling mechanisms of glucoseinduced F-actin remodeling in pancreatic islet β cells. Exp Mol Med 45:e37

[18] Karaskov E, Scott C, Zhang L, Teodoro T, Ravazzola M, Volchuk A (2006) Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic beta-cell apoptosis. Endocrinology 147:3398–3407

[19] Kusminski CM, Shetty S, Orci L, Unger RH, Scherer PE (2009) Diabetes and apoptosis: lipotoxicity. Apoptosis 14:1484–1495

[20] Lapi E, Di Agostino S, Donzelli S, Gal H, Domany E, Rechavi G (2008) PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop. Mol Cell 32:803–814

[21] Maedler K, Spinas GA, Moritz DW, Kaiser N, Donath MY (2001) Distinct effects of saturated and monounsaturated fatty acids on β-cell turnover and function. Diabetes 50:69–76

[22] Marchetti P, Del Guerra S, Marselli L, Lupi R, Masini M, Pollera M(2004) Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J Clin Endocrinol Metab 89:5535–5541

[23] Matsui Y, Lai ZC (2013) Mutual regulation between Hippo signaling and actin cytoskeleton. Protein Cell 4:904–910

[24] Morgan NG, Dhayal S (2009) G-protein coupled receptors mediating long chain fatty acid signalling in the pancreatic beta-cell. Biochem Pharmacol 78:1419–1427

[25] Moroishi T, Park HW, Qin B, Chen Q, Meng Z, Plouffe SW (2015) AYAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis. Genes Dev 29:1271–1284

[26] Natalicchio A, Labarbuta R, Tortosa F, Biondi G, Marrano N, Peschechera A (2013) Expedin-4 protects pancreatic beta cells from palmitate-induced apoptosis by interfering with GPR40 and the MKK4/7 stress kinase signaling pathway. Diabetologia 56:2456–2466

[27] Pan D (2010) The hippo signaling pathway in development and cancer. Dev Cell 19:491–505

[28] Prentki M, Madiraju SR (2011) Glycerolipid/free fatty acid cycle and islet β-cell function in health, obesity and diabetes. Mol Cell Endocrinol 353:88–100

[29] Shimabukuro M, Zhou YT, Levi M, Unger RH (1998) Fatty acidinduced β-cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci 95:2498–2502

[30] Staley BK, Irvine KD (2012) Hippo signaling in Drosophila: recent advances and insights. Dev Dyn 241:3–15

[31] Steneberg P, Rubins N, Bartoov-Shifman R, Walker MD, Edlund H (2005) The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse. Cell Metab 1:245–258

[32] Sun G, Irvine KD (2011) Regulation of Hippo signaling by Jun kinase signaling during compensatory cell proliferation and regeneration, and in neoplastic tumors. Dev Biol 350:139–151

[33] Vetere A, Choudhary A, Burns SM, Wagner BK (2014) Targeting the pancreatic β-cell to treat diabetes. Nat Rev Drug Discov 13:278–289

[34] Wang R, McGrath BC, Kopp RF, Roe MW, Tang X, Chen G (2013) Insulin secretion and Ca2+ dynamics in β-cells are regulated by PERK (EIF2AK3) in concert with calcineurin. J Biol Chem 288:33824–33836

[35] Wu J, Sun P, Zhang X, Liu H, Jiang H, Zhu W (2012) Inhibition of GPR40 protects MIN6 β cells from palmitate-induced ER stress and apoptosis. J Cell Biochem 113:1152–1158

[36] Yu FX, Guan KL (2013) The Hippo pathway: regulators and regulations. Genes Dev 27:355–371

[37] Zhang Y, Xu M, Zhang S, Yan L, Yang C, Lu W (2007) The role of G protein-coupled receptor 40 in lipoapoptosis in mouse betacell line NIT-1. J Mol Endocrinol 38:651–661

[38] Zhang H, Wu S, Xing D (2011) YAP accelerates Aβ(25-35)-induced apoptosis through upregulation of Bax expression by interaction with p73. Apoptosis 16:808–821

[39] Zhao B, Ye X, Yu J, Li L, Li W, Li S (2008) Tead mediates YAPdependent gene induction and growth control. Genes Dev 22:1962–1971

[40] Zhao B, Li L, Lei Q, Guan KL (2010) The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev 24:862–874

RIGHTS & PERMISSIONS

2016 The Author(s) 2016. This article is published with open access at Springerlink.com and journal.hep.com.cn